Publication | Closed Access

Long-Term Renoprotective Effects of Standard Versus High Doses of Telmisartan in Hypertensive Nondiabetic Nephropathies

Hypertensive Nondiabetic NephropathiesHypertensionLong-term Renoprotective EffectsRenal DiseaseRenal FunctionCardiovascular DiseaseMedicineAntihypertensive TherapyDiabetesPharmacologyDiabetic Kidney DiseaseChronic Kidney DiseaseNephrology